Titan Medical Inc.
TMDIF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 12.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 82.1% | 92.7% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | -618.8% | 31.6% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | -666.5% | 15.3% |
| EPS Diluted | -0.009 | -0.007 | -0.029 | 0.001 |
| % Growth | -32.9% | 76% | -5,940% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |